Targeting noncoding RNAs in disease.
Adams, Brian D, Christine Parsons, Lisa Walker, Wen Cai Zhang, and Frank J Slack. 2017. “Targeting Noncoding RNAs in Disease.”. The Journal of Clinical Investigation 127 (3): 761-71.
Search
Search results
222 results found
A role for miR-34 in colon cancer stem cell homeostasis.
Rupaimoole, Rajesha, and Frank J Slack. 2016. “A Role for MiR-34 in Colon Cancer Stem Cell Homeostasis.”. Stem Cell Investigation 3: 42.
ADARs Edit MicroRNAs to Promote Leukemic Stem Cell Activity.
Zhang, Wen Cai, and Frank J Slack. 2016. “ADARs Edit MicroRNAs to Promote Leukemic Stem Cell Activity.”. Cell Stem Cell 19 (2): 141-42.
A novel mechanism of LIN-28 regulation of let-7 microRNA expression revealed by in vivo HITS-CLIP in C. elegans.
Stefani, Giovanni, Xiaowei Chen, Hongyu Zhao, and Frank J Slack. 2015. “A Novel Mechanism of LIN-28 Regulation of Let-7 MicroRNA Expression Revealed by in Vivo HITS-CLIP in C. Elegans.”. RNA (New York, N.Y.) 21 (5): 985-96.
MicroRNA silencing for cancer therapy targeted to the tumour microenvironment.
Cheng, Christopher J, Raman Bahal, Imran A Babar, Zachary Pincus, Francisco Barrera, Connie Liu, Alexander Svoronos, et al. 2015. “MicroRNA Silencing for Cancer Therapy Targeted to the Tumour Microenvironment.”. Nature 518 (7537): 107-10.
MicroRNAs and the cancer phenotype: profiling, signatures and clinical implications.
Stahlhut, Carlos, and Frank J Slack. 2013. “MicroRNAs and the Cancer Phenotype: Profiling, Signatures and Clinical Implications.”. Genome Medicine 5 (12): 111.
Small RNAs deliver a blow to ovarian cancer.
Kasinski, Andrea, and Frank J Slack. 2013. “Small RNAs Deliver a Blow to Ovarian Cancer.”. Cancer Discovery 3 (11): 1220-1.
Joint analysis of expression profiles from multiple cancers improves the identification of microRNA-gene interactions.
Chen, Xiaowei, Frank J Slack, and Hongyu Zhao. 2013. “Joint Analysis of Expression Profiles from Multiple Cancers Improves the Identification of MicroRNA-Gene Interactions.”. Bioinformatics (Oxford, England) 29 (17): 2137-45.
Arresting the Culprit: Targeted Antagomir Delivery to Sequester Oncogenic miR-221 in HCC.
Kasinski, Andrea L, and Frank J Slack. 2012. “Arresting the Culprit: Targeted Antagomir Delivery to Sequester Oncogenic MiR-221 in HCC.”. Molecular Therapy. Nucleic Acids 1 (3): e12.
Nanoparticle-based therapy in an in vivo microRNA-155 (miR-155)-dependent mouse model of lymphoma.
Babar, Imran A, Christopher J Cheng, Carmen J Booth, Xianping Liang, Joanne B Weidhaas, Mark Saltzman, and Frank J Slack. 2012. “Nanoparticle-Based Therapy in an in Vivo MicroRNA-155 (miR-155)-Dependent Mouse Model of Lymphoma.”. Proceedings of the National Academy of Sciences of the United States of America 109 (26): E1695-704.